Research of the Correlation Between Metabolic Syndrome, Retinal Thickness and Visual Acuity

Sponsor
Taipei Medical University WanFang Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01219478
Collaborator
(none)
100
1
11
9.1

Study Details

Study Description

Brief Summary

Purpose: To investigate the relationship between retinal thickness (RT) and metabolic risks (MRs) in patients without retinal lesion.

Methods: Fifty-two patients over 60 y/o were divided into four groups according to their MRs of hypertension, hyperlipidemia or hyperglyceremia. After complete ophthalmic examination, optical coherence tomography was performed to measure RT.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    100 participants
    Time Perspective:
    Retrospective
    Official Title:
    Research of the Correlation Between Metabolic Syndrome, Retinal Thickness and Visual Acuity
    Study Start Date :
    Jan 1, 2009
    Actual Study Completion Date :
    Dec 1, 2009

    Arms and Interventions

    Arm Intervention/Treatment
    control

    0 metabloil risk

    1

    1 metabloil risk

    2

    2 metabloil risk

    3

    3 metabloil risk

    Outcome Measures

    Primary Outcome Measures

      Eligibility Criteria

      Criteria

      Ages Eligible for Study:
      65 Years and Older
      Sexes Eligible for Study:
      All
      Accepts Healthy Volunteers:
      No
      Inclusion Criteria:
      • We enrolled the patients included age more than 60 years old, no positive finding during dilated fundus examination.
      Exclusion Criteria:
      • The exclusion criteria were as followed:

      • systemic disease that will affect visual acuity evaluation (for example: CVA), *opaque cornea and vitreous

      • glaucoma

      • uvietis and other clinically established ocular disease.

      • According to the LOCS III11, those who had nuclear opalescence, nuclear color more than grade 3 or any grade of cortical cataract and posterior subcapsular cataract were also eliminated.

      Contacts and Locations

      Locations

      Site City State Country Postal Code
      1 Taipei Medical University - WanFang Hospital Taipei Taiwan

      Sponsors and Collaborators

      • Taipei Medical University WanFang Hospital

      Investigators

      • Principal Investigator: Hui-Chun Ho, Taipei Medical University WanFang Hospital

      Study Documents (Full-Text)

      None provided.

      More Information

      Publications

      None provided.
      Responsible Party:
      , ,
      ClinicalTrials.gov Identifier:
      NCT01219478
      Other Study ID Numbers:
      • 99028
      First Posted:
      Oct 13, 2010
      Last Update Posted:
      Dec 21, 2010
      Last Verified:
      Dec 1, 2010

      Study Results

      No Results Posted as of Dec 21, 2010